The Health Care M&A Monthly: Medical Devices Dominate with $6.2 Billion in Deals
August belongs to the Medical Devices sector. Not only did it rack up the highest deal volume with 13 transactions out of 59, but it outscored all other sectors in terms of dollars committed to fund those deals. Based on prices revealed to date, a total of $6.2 billon...The Health Care M&A Monthly: Health Care M&A Results for The Second Quarter of 2003
M&A activity in health care remained steady for the second quarter of 2003. A total of 222 transactions were announced in 13 sectors of the health care industry. This represents a 2% decline from the 227 deals in Q1:03, and a 7% decline from the 238 deals in the...The Health Care M&A Monthly: Skilled Nursing Facility Per Bed Prices Hit Six-Year Low
The financial distress suffered by the nursing home industry during the past two years has been well documented. Beginning in the middle of 1999, five of the 10 largest nursing home companies, all publicly traded, filed for bankruptcy protection, as did several...The Health Care M&A Monthly: WellPoint Back in the Saddle With Bid for Wisconsin Blues
One year ago, in our June 2002 issue, the leadoff story predicted that having gone public and turned its finances around, the Wisconsin Blues organization, operating as Cobalt Corporation (NYSE: CBZ), would probably become an acquisition target. That story also named...The Health Care M&A Monthly: Chiron Buys Vaccine Producer PowderJect for $878 Million
For the third time this year, our deal of the month involves a transaction in the Biotech sector. California’s Chiron Corp. (NASDAQ: CHIR) has agreed to buy Britain’s PowderJect Pharmaceuticals (LSE: PJP) for £542 million, or approximately $878 million. This purchase,...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
